Plain-English translation of NCT07377279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Taxane-based chemotherapy is an important part of breast cancer treatment, but it can cause painful nerve damage in the hands and feet (called chemotherapy-induced peripheral neuropathy, or CIPN) in up to 7 out of 10 patients. This trial is testing whether two non-drug approaches—compression gloves and stockings worn during chemotherapy, and acupuncture treatments given after each chemotherapy cycle—can prevent or reduce this nerve damage.
Currently, there are no proven ways to prevent this type of nerve damage from developing. This trial aims to find out whether the medication can be made safer and more tolerable by using these complementary approaches before nerve damage starts.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to wear compression gloves and stockings during chemotherapy, receive acupuncture treatments after each chemotherapy cycle, try both approaches together, or receive sham (placebo) acupuncture as a control. The compression therapy is worn during your regular chemotherapy sessions, and the real or sham acupuncture treatments happen for 3–5 days after each cycle. The study will monitor your nerve function and quality of life throughout your chemotherapy and beyond.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China